ACRO’s Good Clinical Podcast
Membership
Current Members
Initiatives
Clinical Research Roundtables
COVID-19
CRO Forum
Decentralized Trials
Diversity and Inclusion in Clinical Trials
Risk-Based Quality Management
Advocacy
US Legislation & Regulation
European Legislation & Regulation
Global Data Protection & Privacy
CFO Roundtable
About
ACRO Membership
Our Mission
Leadership
News
Subscribe
Facts & Figures on Clinical Research
Clinical Trial Resources for Patients
20th Anniversary
Contact Us
RBQM Summary Report
Currently Browsing: Resources
Visit Our Blog
Central Drugs Standard Control Organisation Guidance: Rapid Response Regulatory Framework for COVID-19 Vaccine development -reg.
June 9, 2020
Food and Drug Administration Guidance: COVID-19: Developing Drugs and Biological Products for Treatment or Prevention
June 2, 2020
Health Canada Guidance: Applications for drug clinical trials under the Interim Order
June 2, 2020
National Medical Product Administration Blogpost: Research well underway into COVID-19 vaccines and drugs, premier says
June 2, 2020
Food and Drug Administration Guidance: FDA Combatting COVID-19 with Medical Devices
May 27, 2020
Federal Institute for Drugs and Medical Devices Guidance: Supplementary Recommendations to EU Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic (Version 3.0)
May 27, 2020
European Medicines Agency Report: Treatments and vaccines for COVID-19
May 27, 2020
National Institute for Health Research Guidance: A framework for restarting NIHR research activities which have been paused due to COVID-19
May 21, 2020
European Medicines Agency Guidance: Guidance for medicine developers and companies on COVID-19
May 8, 2020
Food and Drug Administration Blogpost: Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy
May 8, 2020
Food and Drug Administration Press Release: Coronavirus (COVID-19) Update: FDA Continues to Ensure Availability of Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic, Addresses Safety Concerns
April 30, 2020
European Medicines Agency Press Release: International regulators pledge collective support to combat COVID-19 pandemic
April 30, 2020
Food and Drug Administration Blogpost: The Path Forward: Coronavirus Treatment Acceleration Program
April 30, 2020
European Commission Press Release: Coronavirus: Commission issues guidance to mitigate clinical trial disruption in the EU
April 28, 2020
National Medical Products Administration Press Release: China to speed up resuming normal medical services in low-risk regions
April 23, 2020
Food and Drug Administration Press Release: Coronavirus (COVID-19) Update: FDA Authorizes First Test for Patient At-Home Sample Collection
April 23, 2020
Medicines and Healthcare products Regulatory Agency Guidance: MHRA regulatory flexibilities resulting from coronavirus (COVID-19)
April 23, 2020
European Medicines Agency Press Release: Launch of enhanced monitoring system for availability of medicines used for treating COVID-19
April 23, 2020
European Commission Notice: Questions and Answers on Regulatory Expectations for Medicinal Products for Human Use during the COVID-19 Pandemic
April 23, 2020
Food and Drug Administration Guidance: Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Outsourcing Facilities During the COVID-19 Public Health Emergency
April 21, 2020
1
2